LifeScan launched a new version of its OneTouch Reveal mobile app with three new features that provide even more insight to support diabetes management. The app has been the number one downloaded diabetes app in the United States and Canada since 2017 and is one of the most downloaded diabetes apps in the world.
The OneTouch Reveal mobile app serves as a diabetes management tool that can help people with diabetes track their blood sugar from their phone and easily share results with their healthcare team and loved ones. Adding to the app’s key feature of drawing a timeline of important blood sugar events and activities organized in a color-coded digital logbook, the just-released version of the OneTouch Reveal mobile app now includes the following features:
- Automatic recurring high or low patterns notifications – there are five different messages, including: High pattern detected (1 week); Low pattern detected (1 week); High recurring pattern detected (over last 14 days); Low recurring pattern detected (last 14 days); and a Sync reminder.
- Goal setting and tracking – allows users to set and track personalized goals for blood glucose tests, carbohydrates logging, and number of steps taken per day.
- Meaningful monitoring – new A1C comparator shows users their 90-day-average compared to the inputted lab A1c so they can see how their blood sugar has been over the time.
The OneTouch Reveal mobile app seamlessly syncs with the OneTouch Verio Flex blood glucose monitoring (BGM) system with built-in Bluetooth Smart Technology. Together, these tools help patients to understand their blood glucose numbers, take action to get back in range, and get on with life.
The OneTouch Reveal mobile app is available as a free download for iPhone and Android devices in 24 countries globally — including Argentina, Algeria, Austria, Belgium, Brazil, Canada, Colombia, Czech Republic, Chile, Croatia, France, Germany, India, Italy, Ireland, Mexico, Poland, Portugal, Qatar, Slovenia, Spain, the United Arab Emirates, the United Kingdom, and the United States.